BriaCell Therapeutics Corp. (BCTXL) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$0.90

From 52W high−26.84%

Volume37103.00

Market cap$7.83M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$0.90

From 52W high

−26.84%

Volume

37103.00

Market cap

$7.83M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

P/E (TTM)

—

RSI (14)

40.6

MomentumView details →

1D Return

+0.21%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

—

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

—

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

—

ROA (TTM)

—

Asset Turnover

—

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

—

EBITDA YoY

—

MomentumView details →

1D Return

+0.21%

YTD Return

—

1Y Return

—

RSI (14)

40.6

vs 50D SMA

—

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

—

Quick Ratio

—

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

—

Net Income (TTM)

—

Op. CF (TTM)

—

Latest newsMore news →

No recent news for BCTXL.

Similar companies

Karyopharm Therapeutics Inc.KPTI Bolt Biotherapeutics, Inc.BOLT Immuron LimitedIMRN Curanex Pharmaceuticals Inc Common StockCURX Alaunos Therapeutics, Inc.TCRT MetaVia Inc.MTVA Find similar companies →

Latest newsMore news →

No recent news for BCTXL.